№ lp_2_1_03481
File format: docx
Character count: 3205
File size: 26 KB
Year:
2024
Region / City:
New Zealand
Topic:
Gene technology, GMO regulations
Document type:
Submission
Agency / Organization:
Not specified
Author:
Not specified
Target Audience:
Government officials, regulatory bodies
Effective Period:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2024
Region / City:
Africa
Topic:
Vector Control, Malaria, Genetically Modified Organisms
Document Type:
Consultancy Announcement
Organization:
African Union Development Agency-NEPAD (AUDA-NEPAD)
Author:
Not specified
Target Audience:
Individual Consultants
Period of Validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Note:
Year
Contextual description:
A document detailing various gene therapy techniques, case studies, and activities focused on genetics and gene therapy methods, including CRISPR, cystic fibrosis, and reproductive technologies.
Note:
Year
Year:
2017
Region / City:
Lancaster County, South Carolina
Topic:
Education, Leadership
Document Type:
Resolution
Author:
South Carolina House of Representatives
Target Audience:
General public, local community
Date of Approval:
2017
Date of Changes:
None
Year:
2026
Region / city:
Mississippi
Topic:
Healthcare, Medicaid, Cell & Gene Therapy Access
Document type:
Request for Applications (RFA)
Institution:
Mississippi Division of Medicaid
Author:
Office of Procurement
Target audience:
Qualified applicants for Model Care Coordinator/Grant Manager position
Period of validity:
April 1, 2026 - December 31, 2030
Approval date:
N/A
Amendment date:
N/A
Year:
2023
Region / City:
N/A
Topic:
Gene-Disease Relationship Curation
Document Type:
Guidelines
Organization / Institution:
ClinGen
Author:
N/A
Target Audience:
Researchers, Clinicians
Period of Validity:
Ongoing
Approval Date:
November 1, 2023
Modification Date:
N/A
Note:
Year
Author:
Andreas Fønss Møller, Kedar Nath Natarajan
Note:
Year
Region / City:
United States
Topic:
Pharmaceutical naming and regulatory processes
Document type:
Application form
Organization / Institution:
United States Adopted Names Council, American Medical Association
Target audience:
Pharmaceutical companies, researchers, regulatory authorities
Year:
2025
Region / city:
Philadelphia, PA
Theme:
Cell and gene therapy, CAR-T cell therapy, cancer treatment
Document type:
Symposium agenda
Author:
Various speakers from Penn Medicine and affiliated institutions
Target audience:
Hematologist-oncologists, medical oncologists, immunologists, researchers, healthcare professionals, patients and caregivers
Period of validity:
April 30, 2025 - May 2, 2025
Approval date:
Not specified
Date of changes:
Not specified
Year:
2023
Region / City:
Wuhan, China
Topic:
Gene expression, liver fibrosis, HCC
Document Type:
Research Article
Organization / Institution:
Zhongnan Hospital of Wuhan University, Wuhan University
Author:
Not specified
Target Audience:
Researchers, clinicians, medical professionals
Duration:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Note:
Context
Document type:
Supplemental table
Subject:
Summary of nominated genetic variants per gene
Content:
Gene symbols, HGNC Gene IDs, number of variants nominated, associated disorders, ACMG 73 List status
Referenced policy:
ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing
Referenced organization:
American College of Medical Genetics and Genomics (ACMG)
Referenced publication:
Genet Med (2021)
Authors of referenced policy:
Miller, D.T.; Lee, K.; Chung, W.K.; et al.
Notes:
Includes annotations regarding multi-gene deletions or fusions and dual submissions to variant curation expert panels
Note:
Year
Subject:
Gene Transfer, Targeting, and Therapeutics
Document Type:
Request Form
Organization / Institution:
Salk Institute
Target Audience:
Researchers and Lab personnel
Context:
A form for requesting viral vectors from the Gene Transfer, Targeting, and Therapeutics Facility at the Salk Institute for scientific research purposes.
Date:
June 14-16, 2022
Region / City:
Haifa, Israel
Topic:
Brain health, neuroscience, gene-environment interactions
Document Type:
Conference Program
Organizer:
Integrated Brain and Behavior Research Center
Target Audience:
Researchers, academics, and professionals in neuroscience and psychology
Period of Action:
June 14-16, 2022
Approval Date:
Not specified
Date of Changes:
Not specified
Context:
Conference program for the 9th International Meeting focused on the intersection of gene-environment interactions in brain health and disease.
Year:
2023
Region / City:
Laboratory / Research Setting
Topic:
Atherosclerosis, FXR1 Protein, IL-19, Gene Expression
Document Type:
Research Report
Institution:
Unspecified Research Institution
Author:
Unspecified Researcher
Target Audience:
Researchers in Genetics and Molecular Biology
Period of Activity:
Ongoing
Date of Approval:
Unspecified
Date of Changes:
Unspecified
Year:
2018
Document Type:
Coverage guidance / HTA report
Medical Field:
Oncology, Breast Cancer
Procedure Codes:
81518, 81519, 81520, 81521
Test Names:
Breast Cancer Index, Oncotype DX, Prosigna, Mammaprint
Methodology:
mRNA gene expression profiling, RT-PCR, hybrid capture, microarray
Tissue Type:
Formalin-fixed paraffin-embedded, fresh frozen
Algorithms:
Recurrence risk score, metastatic recurrence percentage, likelihood of benefit from extended endocrine therapy
Review Body:
HERC
Last Review Date:
November 2018
Coverage Recommendation:
Limited / not covered
Previous Guidance:
May 2018
St. John's Fire District Bill - H. 5060 - South Carolina General Assembly, 126th Session (2025-2026)
Year:
2026
Region / City:
South Carolina
Subject:
Legislation
Document Type:
Bill
Institution:
South Carolina General Assembly
Author:
Rep. Stavrinakis
Target Audience:
Residents of South Carolina, government officials
Period of Action:
2025-2026
Approval Date:
TBD
Amendment Date:
2026
Year:
2026
Region / City:
West Virginia
Topic:
Real Estate Transactions, Settlement Process
Document Type:
Legislative Bill
Organization / Institution:
West Virginia Legislature
Author:
Senator Morris
Target Audience:
Legislators, Legal Professionals, Real Estate Practitioners
Period of Validity:
2026
Date of Approval:
January 29, 2026
Date of Amendments:
N/A
Year:
2025-2026
Region / City:
South Carolina
Topic:
Critical Infrastructure
Document Type:
General Bill
Institution:
South Carolina General Assembly
Author:
Rep. Gilliam, Rep. Rankin, Rep. Yow, Rep. C. Mitchell, Rep. Haddon
Target Audience:
Lawmakers, Government Agencies, Businesses
Period of Effect:
2026 and onwards
Approval Date:
Not specified
Amendments Date:
Not specified
Year:
2025
Region / city:
Ghana
Theme:
Electronic communications, broadcasting, digital services
Document type:
Bill
Organization:
National Communications Authority
Author:
National Communications Authority
Target audience:
Licensed service providers, industry stakeholders, civil society organizations, consumers, general public
Period of validity:
From 16th October 2025 to 29th October 2025
Approval date:
16th October 2025
Amendment date:
N/A
Year:
2025
Region / City:
West Virginia
Subject:
Fire Protection Services
Document Type:
Legislation
Organization / Institution:
West Virginia Legislature
Author:
Delegate Burkhammer
Target Audience:
Government authorities, municipalities, and businesses affected by fire protection fees
Effective Date:
July 9, 2025
Date of Approval:
April 10, 2025
Date of Amendments:
Not specified